Hong-Min Ni1, Xiaojuan Chao1, Hua Yang1,2, Fengyan Deng1, Shaogui Wang1, Qingyun Bai1,3,4, Hui Qian1, Yue Cui5, Wei Cui6, Yinghong Shi7, Wei-Xing Zong8, Zhengtao Wang3, Li Yang3, Wen-Xing Ding1. 1. Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS. 2. Department of General Surgery, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. 3. Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China. 4. School of Chemical and Biological Engineering, Yichun University, Jiangxi, China. 5. Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA. 6. Department of Pathology, University of Kansas, Medical Center, Kansas City, KS. 7. Department of Liver Surgery & Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China. 8. Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ.
Abstract
Autophagy is a lysosomal degradation pathway that degrades cytoplasmic proteins and organelles. Absence of autophagy in hepatocytes has been linked to promoting liver injury and tumorigenesis; however, the mechanisms behind why a lack of autophagy induces these complications are not fully understood. The role of mammalian target of rapamycin (mTOR) in impaired autophagy-induced liver pathogenesis and tumorigenesis was investigated by using liver-specific autophagy related 5 knockout (L-ATG5 KO) mice, L-ATG5/mTOR, and L-ATG5/Raptor double knockout (DKO) mice. We found that deletion of mTOR or Raptor in L-ATG5 KO mice at 2 months of age attenuated hepatomegaly, cell death, and inflammation but not fibrosis. Surprisingly, at 6 months of age, L-ATG5/mTOR DKO and L-ATG5/Raptor DKO mice also had increased hepatic inflammation, fibrosis, and liver injury, similar to the L-ATG5 KO mice. Moreover, more than 50% of L-ATG5/mTOR DKO and L-ATG5/Raptor DKO mice already developed spontaneous tumors, but none of the L-ATG5 KO mice had developed any tumors at 6 months of age. At 9 months of age, all L-ATG5/mTOR DKO and L-ATG5/Raptor DKO had developed liver tumors. Mechanistically, L-ATG5/mTOR DKO and L-ATG5/Raptor DKO mice had decreased levels of hepatic ubiquitinated proteins and persistent nuclear erythroid 2 p45-related factor 2 activation but had increased Akt activation compared with L-ATG5 KO mice. Conclusion: Loss of mTOR signaling attenuates the liver pathogenesis in mice with impaired hepatic autophagy but paradoxically promotes tumorigenesis in mice at a relatively young age. Therefore, the balance of mTOR is critical in regulating the liver pathogenesis and tumorigenesis in mice with impaired hepatic autophagy.
Autophagy is a lysosomal degradation pathway that degrades cytoplasmic proteins and organelles. Absence of autophagy in hepatocytes has been linked to promoting liver injury and tumorigenesis; however, the mechanisms behind why a lack of autophagy induces these complications are not fully understood. The role of mammalian target of rapamycin (mTOR) in impaired autophagy-induced liver pathogenesis and tumorigenesis was investigated by using liver-specific autophagy related 5 knockout (L-ATG5 KO) mice, L-ATG5/mTOR, and L-ATG5/Raptor double knockout (DKO) mice. We found that deletion of mTOR or Raptor in L-ATG5 KO mice at 2 months of age attenuated hepatomegaly, cell death, and inflammation but not fibrosis. Surprisingly, at 6 months of age, L-ATG5/mTOR DKO and L-ATG5/Raptor DKO mice also had increased hepatic inflammation, fibrosis, and liver injury, similar to the L-ATG5 KO mice. Moreover, more than 50% of L-ATG5/mTOR DKO and L-ATG5/Raptor DKO mice already developed spontaneous tumors, but none of the L-ATG5 KO mice had developed any tumors at 6 months of age. At 9 months of age, all L-ATG5/mTOR DKO and L-ATG5/Raptor DKO had developed liver tumors. Mechanistically, L-ATG5/mTOR DKO and L-ATG5/Raptor DKO mice had decreased levels of hepatic ubiquitinated proteins and persistent nuclear erythroid 2 p45-related factor 2 activation but had increased Akt activation compared with L-ATG5 KO mice. Conclusion: Loss of mTOR signaling attenuates the liver pathogenesis in mice with impaired hepatic autophagy but paradoxically promotes tumorigenesis in mice at a relatively young age. Therefore, the balance of mTOR is critical in regulating the liver pathogenesis and tumorigenesis in mice with impaired hepatic autophagy.
Authors: Wendong Huang; Jun Zhang; Michele Washington; Jun Liu; John M Parant; Guillermina Lozano; David D Moore Journal: Mol Endocrinol Date: 2005-04-14
Authors: Youngmin A Lee; Luke A Noon; Kemal M Akat; Maria D Ybanez; Ting-Fang Lee; Marie-Luise Berres; Naoto Fujiwara; Nicolas Goossens; Hsin-I Chou; Fatemeh P Parvin-Nejad; Bilon Khambu; Elisabeth G M Kramer; Ronald Gordon; Cathie Pfleger; Doris Germain; Gareth R John; Kirk N Campbell; Zhenyu Yue; Xiao-Ming Yin; Ana Maria Cuervo; Mark J Czaja; M Isabel Fiel; Yujin Hoshida; Scott L Friedman Journal: Nat Commun Date: 2018-11-23 Impact factor: 17.694
Authors: Feng He; Laura Antonucci; Shinichiro Yamachika; Zechuan Zhang; Koji Taniguchi; Atsushi Umemura; Georgia Hatzivassiliou; Merone Roose-Girma; Miguel Reina-Campos; Angeles Duran; Maria T Diaz-Meco; Jorge Moscat; Beicheng Sun; Michael Karin Journal: J Hepatol Date: 2020-02-24 Impact factor: 25.083